Niger vs Portugal: HIV/AIDS deaths averted by antiretroviral therapy
Niger
1,361 deaths
in 2024
Portugal
1,420 deaths
in 2024
Niger rank
67th
Portugal rank
66th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Niger
- Portugal
How they compare
Portugal currently reports 1,420 deaths against 1,361 deaths in Niger, a difference of 59 deaths.
Across all 35 years both countries report, Portugal has been ahead every year.
Niger ranks 67th and Portugal ranks 66th of 157 countries.
Portugal has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Niger | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 125.06 deaths | 125.06 deaths | Portugal |
| 2000s | 290.37 deaths | 1,361 deaths | 1,071 deaths | Portugal |
| 2010s | 1,440 deaths | 1,650 deaths | 210.23 deaths | Portugal |
| 2020s | 1,431 deaths | 1,458 deaths | 27.67 deaths | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Niger or Portugal?
- Portugal, at 1,420 deaths against 1,361 deaths in Niger as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Niger and Portugal?
- 59 deaths, with Portugal ahead.
- How many years of comparable data are there for Niger and Portugal?
- 35 years are reported by both, from 1990 to 2024.
- How do Niger and Portugal rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Niger ranks 67th and Portugal ranks 66th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.